Jump to Navigation
Edwards Lifesciences Management Discusses Q1 2014 Results...
Fair Isaac's CEO Discusses Q2 2014 Results -...
Abaxis' CEO Discusses Q1 2014 Results - Earnings...
Amazon's revenue increases even as spending rises
Neutral net may be a lost cause
Recruitment firms court tricky mandates
Microsoft beats Wall Street on new CEO debut
Advertising: A Supplement Retailer Pumps Up Consumers
Former KPMG partner sentenced for insider trading
Guest Post: Demography + Debt = Doom
Good News for Vical Cancer Drug Candidate
Vical, Inc. Q4 2009 Earnings Call Transcript
Biotech Deal Activity Takes a Breather
7 Companies in the Race to Find Cures for Cancer
Vical Incorporated Q1 2010 Earnings Call Transcript
Vical Incorporated. Q2 2010 Earnings Call Transcript
Sanofi Failure Opens Door for Aastrom Bio
Bottom Fishing: Any Value in September's Losers?
15 Biotech Stocks With the Lowest Put/Call Ratios
Vical Analyst and Investor Day Transcript
Seven Stocks With CEO Buying in the Past Week
Vical CEO Discusses Q4 2010 Results - Earnings Call Transcript
18 Stocks on the 52 Week Low List Ready to Pop?
Ipilimumab Approval Highlights Active Immunotherapy Renaissance
Vical Is Deeply Undervalued: Technology and Pipeline Offer Upside Reward
Major FDA Approval Could Pave the Way for These 5 Biotechs
Vical: A Biotech Flying Under the Radar
Chinese CEOs: Cook Your Books at Your Own Peril
7 Dirt Cheap Biotech Stocks With Huge Upside
Breakouts: 6 Stocks Showing New Strength
Vical's CEO Discusses Q1 2011 Results - Earnings Call Transcript
4 Biotech Stocks with Extremely Bearish Options Sentiment
Personalized Medicine for the Masses
Careful Analysis Reveals Good Probability of Gains for Vical
The Best Cities To Find A Job If You're A...
Famous Movie Scene Locations As Seen Through...
Create new account
Request new password
Click on the icon to sign in with your social network login or enter your Bullfax.com login
EUR/GBP: 1.2148 USD/EUR: 1.3833 JPY/USD: 102.405
Bullfax.com - Market News & Analysis 2008-2011
Terms & Conditions